Scienture Drug Patent Portfolio
Scienture owns 2 orange book drugs protected by 3 US patents Given below is the list of Scienture's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11890273 | Losartan liquid formulations and methods of use | 07 Oct, 2041 | Active |
| US12156869 | Losartan liquid formulations and methods of use | 07 Oct, 2041 | Active |
| US12514854 | Drug Products For Intranasal Administration And Uses Thereof | 05 Feb, 2041 | Active |
Latest Legal Activities on Scienture's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Scienture.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Date Forwarded to Examiner | 23 Oct, 2025 | US12514854 |
| Disposal for a RCE / CPA / R129 | 23 Oct, 2025 | US12514854 |
| Request for Continued Examination (RCE) | 22 Oct, 2025 | US12514854 |
| Information Disclosure Statement (IDS) Filed | 22 Oct, 2025 | US12514854 |
| Workflow - Request for RCE - Begin | 22 Oct, 2025 | US12514854 |
| Terminal Disclaimer Filed | 22 Oct, 2025 | US12514854 |
| Mail Examiner Interview Summary (PTOL - 413) | 17 Oct, 2025 | US12514854 |
| Email Notification | 17 Oct, 2025 | US12514854 |
| Interview Summary - Applicant Initiated - Telephonic | 14 Oct, 2025 | US12514854 |
| Interview Summary Record | 14 Oct, 2025 | US12514854 |
| Electronic request for Examiner Interview | 08 Oct, 2025 | US12514854 |
| Change in Power of Attorney (May Include Associate POA) | 11 Sep, 2025 | US12514854 |
| Email Notification | 11 Sep, 2025 | US12514854 |
| Electronic Review | 22 Jul, 2025 | US12514854 |
| Mail Final Rejection (PTOL - 326) | 22 Jul, 2025 | US12514854 |
Scienture's Family Patents
Scienture Drug List
Given below is the complete list of Scienture's drugs and the patents protecting them.
1. Arbli
Arbli is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11890273 | Losartan liquid formulations and methods of use |
07 Oct, 2041
(15 years from now)
| Active |
| US12156869 | Losartan liquid formulations and methods of use |
07 Oct, 2041
(15 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Arbli's drug page
2. Rezenopy
Rezenopy is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12514854 | Drug Products For Intranasal Administration And Uses Thereof |
05 Feb, 2041
(14 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rezenopy's drug page